Search for European Projects

30 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Cardiac Connective Tissue: Beat-by-Beat Relevance for Heart Function in Health and Disease (CARDIONECT)

Start date: Jul 1, 2013, End date: Jun 30, 2019,

Cardiac connective tissue is regarded as passive in terms of cardiac electro-mechanics. However, recent evidence confirms that fibroblasts interact directly with cardiac muscle cells in a way that is likely to affect their beat-by-beat activity.To overcome limitations of traditional approaches to exploring these interactions in native tissue, we will build and explore murine models that express fu ...
Read Project

 3

 FINISHED 

Epigenetic modifications in glomerular nephropathy and renal aging (RENAL EPIGENETICS)

Start date: Sep 1, 2011, End date: Nov 11, 2018,

Here, we propose a program to identify the role of mTOR and autophagy dependent epigeneticmodifications during kidney aging. We have assembled a unique set of complementary mouse models including kidney specific and timely inducible autophagy and mTOR deficient mice. For the detailed molecular analysis of transgenic podocyte tissue, we have generated a double-labeled transgenic mouse model, where ...
Read Project

 1

 FINISHED 

Systems biology for the functional validation of genetic determinants of skeletal diseases (SYBIL)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

"The aim of SYBIL is to carry out extensive functional validation of the genetic determinants of rare and common skeletal diseases and the age related factors contributing to these painful conditions. To achieve this goal SYBIL will gather complementary translational and transnational scientists, systems biologists, disease modellers, leading SMEs and industrialists that will perform in-depth char ...
Read Project

 19

 FINISHED 

nEUROinflammation

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Neuroinflammation is a hallmark of multiple sclerosis and ischemic stroke. Investigating neuroinflammation as a common theme in neurological disorders, this ITN will focus in particular on myeloid cells, microglia, and endothelial cells. Sixteen partners from the academic and private sector with complementary scientific background join forces to train 13 ESRs in neuroinflammatory concepts and tech ...
Read Project

 13

 FINISHED 

Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (Neuromics)

Start date: Oct 1, 2012, End date: Sep 30, 2017,

Neurodegenerative (ND) and neuromuscular (NM) disease is one of the most frequent classes of rare diseases, affecting life and mobility of 500,000 patients in Europe and millions of their caregivers, family members and employers. This NEUROMICS project brings together the leading research groups in Europe, five highly innovative SMEs and relevant oversea experts using the most sophisticated Omics ...
Read Project

 20

 FINISHED 

Rapid Adaptive Nonlinear Gradient Encoding for Magnetic Resonance Imaging (RANGEmri)

Start date: Feb 1, 2012, End date: Jan 31, 2017,

The project is aimed at the development of novel approaches for flexible signal localisation and encoding in Magnetic Resonance Imaging (MRI) for applications in neuroscience, neurology, oncology and further areas. The Rapid Adaptive Nonlinear Gradient Encoding for Magnetic Resonance Imaging (RANGE) methodology is based on the concept of applying localised, generally nonlinear encoding fields to f ...
Read Project

 1

 FINISHED 

A Decision Support System incorporating a validated patient-specific, multi-scale Balance Hypermodel towards early diagnostic Evaluation and efficient Management plan formulation of Balance Disorders (EMBalance)

Start date: Dec 1, 2013, End date: Nov 30, 2016,

Human balance is achieved and maintained by a complex set of sensorimotor systems that include sensory input from vision, proprioception and the vestibular system (motion, equilibrium, spatial orientation); integration of the sensory input; and motor output to the muscles of the eye and body. Failure at the level of the sensory inputs or at the integration of the sensory information by the central ...
Read Project

 10

 FINISHED 

NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE (TRANSEURO)

Start date: Jan 1, 2010, End date: Jun 30, 2016,

There are currently no cures for Parkinson's disease (PD) but one of the most effective reparative therapies in patients to date has been with allotransplants of dopamine (DA) neuroblasts obtained from fetal ventral mesencephalic (VM) tissue. However, this cell transplantation approach has given inconsistent results, with some patients doing extremely well and coming off anti-PD medication for yea ...
Read Project

 15

 FINISHED 

Software for the Use of Multi-Modality images in External Radiotherapy (SUMMER)

Start date: Jan 1, 2012, End date: Dec 31, 2015,

"The greatest challenge for radiation therapy is to reach the highest probability of cure with the least morbidity. In practice, some difficulties remain to identify cancer cells, target them with radiation and minimize collateral damage. Over the last decades, remarkable progress has been made thanks to modern advances in computer and imaging technologies. Currently, the radiotherapy has reached ...
Read Project

 7

 FINISHED 

Advanced multifunctional zirconia ceramics for long-lasting implants (LONGLIFE)

Start date: Jan 1, 2012, End date: Jun 30, 2015,

The aim of LONGLIFE is to develop new multi-functional zirconia oral and spine (lumbar inter-vertebral disc) implants, with a perfect reliability and a lifetime longer than 60 years. Such an ambitious goal, motivated by the risks and costs associated to revision surgery, will only be reachable by an improvement of the Low Temperature Degradation (LTD) resistance of zirconia and by an enhancement o ...
Read Project

 13

 FINISHED 

A systems biology approach to dissect cilia function and its disruption in human genetic disease (SYSCILIA)

Start date: Jun 1, 2010, End date: May 31, 2015,

AIM: To identify the molecular mechanisms characterizing cilium function, and the discrete perturbations associated with dysfunction caused by mutations in inherited ciliopathies, applying a systems biology approach. BACKGROUND: Cilia are microtubule-based, centriole-derived projections from the cell surface. They transduce extracellular signals and regulate key processes in which signals of the e ...
Read Project

 17

 FINISHED 

Ultra Fast Magnetic Resonance Imaging using One-Voxel-One-Coil Acquisition (OVOC)

Start date: Sep 1, 2009, End date: Feb 28, 2015,

The proposal is aimed at the development of ultrafast Magnetic Resonance Imaging (MRI) for applications in neuroscience, neurology and oncology. The methodology used is based on the principle of one-voxel-one-coil acquisition in which the sensitive volumes of arrays containing a large number of small receiver coils is used as primary source of spatial localization. This allows to achieve acquisiti ...
Read Project

 2

 FINISHED 

PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort (PRESTIGE)

Start date: Dec 1, 2010, End date: Nov 30, 2014,

"According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous ...
Read Project

 16

 FINISHED 

Experimental Radiotherapy for Malignant Brain Tumours (ERTMABTU)

Start date: Sep 1, 2010, End date: Aug 31, 2014,

"The aim of my project is to test two novel experimental radiotherapies which potentially can improve the quality life in patients with malignant brain tumours or with multiple brain metastases. Both methods are being developed at international synchrotron facilities. One of the techniques, microbeam radiation therapy (MRT), is already being studied by several groups and my work is focused on the ...
Read Project

 1

 FINISHED 

Identification of the genetic and/or epigenetic events that lead to mesenchymal transformation in glioblastoma (GAMNG)

Start date: Oct 1, 2010, End date: Jul 6, 2014,

"Glioblastoma multiforme (GBM) is the most malignant type of brain tumor in adults with a median survival of one year. The hallmarks of GBM are invasion and neo-angiogenesis. Recently, gene expression studies have established that overexpression of a “mesenchymal” gene signature co-segregate with the poor-prognosis group of glioma patients. We have revealed that two transcription factors, Stat3 an ...
Read Project

 1

 FINISHED 

Prevention of Hospital Infections by Intervention and Training (PROHIBIT)

Start date: Jan 1, 2010, End date: Jun 30, 2014,

"The aim of PROHIBIT is to understand existing guidelines and practices to prevent healthcare associated infections (HAI) in European hospitals, identify factors that enable and prevent compliance with best practices, and test the effectiveness of interventions of known efficacy. The project will employ a mixed-methods approach combining the strengths of qualitative research, survey methods, obser ...
Read Project

 11

 FINISHED 

Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences (Euro-BioImaging)

Start date: Dec 1, 2010, End date: May 31, 2014,

Euro-BioImaging brings together imaging technologies stretching from basic biological imaging with advanced light microscopy, in vivo molecular imaging of single cells to animal models up to the clinical and epidemiological level of medical imaging of humans and populations. Euro-BioImaging, in close consultation with its stakeholders, will address the imaging requirements of both biological and m ...
Read Project

 44

 FINISHED 

Pharmaceutical Medicine Training Programme (PHARMATRAIN)

Start date: May 1, 2009, End date: Apr 30, 2014,

"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety and regulatory scientists from universities, regulatory agencies, large, middle-sized and small pharmaceutical enterprises, ...
Read Project

 52

 FINISHED 

Medical Imaging Using Bio-inspired and Soft Computing (MIBISOC)

Start date: Oct 1, 2009, End date: Sep 30, 2013,

"Medical imaging (MI) is at the heart of many of today’s improved diagnostic and treatment technologies. Computer-based solutions are vastly more capable of both quantitative measurement of the medical condition and the pre-processing tasks of filtering, sharpening, and focusing image detail. Bio-inspired and Soft Computing (BC, SC) techniques have been successfully applied in each of the fundamen ...
Read Project

 8

 FINISHED 

Use of innovative strategies for beta-cell imaging in diabetes mellitus (BetaImage)

Start date: Oct 1, 2008, End date: Mar 31, 2013,

The development of sensitive, non-invasive methods for the characterisation and quantification of beta-cell mass would greatly enhance our means for gaining understanding of the pathophysiology of diabetes and allow the development of novel therapies to prevent, halt and reverse the disease. The aim of this project is to develop and apply innovative approaches for beta-cell imaging, the emphasis b ...
Read Project

 10

 FINISHED 

Development of sensitive methodologies for exploitation of early epigenetic marker diagnosis in major types of cancer (EpiDiaCan)

Start date: Jan 1, 2010, End date: Dec 31, 2012,

Cancer is one of the major causes of mortality. Epithelial cells become malignant after accumulating genetic mutations followed by morphological changes in the epithelium. DNA Alterations include stable genetic changes in oncogenes, tumor suppressor genes and reversible epigenetic changes. Different forms of epigenetic mechanisms have been shown to modify the expression of key genes during tumour ...
Read Project

 7

 FINISHED 

Promotion of plasticity as a treatment for neurodegenerative conditions (PLASTICISE)

Start date: Dec 1, 2008, End date: Nov 30, 2012,

"Neurodegenerative diseases all cause damage to the circuitry of the nervous system, with loss of connections, axons and neurons. The loss can be gradual, as in Alzheimer’s disease, rapid as in stroke, or intermediate as in the delayed neuronal loss after stroke. Following damage, the nervous system is able partially to compensate through the formation of alternative connections and pathways, a pr ...
Read Project

 16

 FINISHED 

European Network for Cell Imaging and Tracking Expertise (ENCITE)

Start date: Jun 1, 2008, End date: Nov 30, 2012,

"Cell therapy can be defined as the transplantation of living cells for the treatment of medical disorders. Three different principles underlie the increasing interest in cell therapy. 1. Transplanted cells used as an “active drug” 2. Transplanted cells used to replace damaged and degenerated tissue. 3. Cells used as a drug delivery vehicle. Promising results have been obtained in pre-clinical and ...
Read Project

 30

 FINISHED 

Evolving Platform for Improving Living Expectation of Patients Suffering from IctAl Events (EPILEPSIAE)

Start date: Jan 1, 2008, End date: Dec 31, 2011,

Epilepsy is the commonest serious brain disorder in every country, and probably the most universal of all medical disorders. In Europe six million people currently have epilepsy and fifteen million will have epilepsy at some time of their lives. Currently nearly 30% of these people cannot be treated by therapeutics based on pharmacological anticonvulsive medication or resective surgery and are com ...
Read Project

 7

 FINISHED 

Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response (DEVANI)

Start date: Jan 1, 2008, End date: Jun 30, 2011,

"Direct vaccination cannot prevent diseases that affect neonates in the first days of life. Group B Streptococcus (GBS) is the major cause of neonatal septicemia and meningitis affecting up to one in every thousand live births. Over 80% of cases occur in the first 7 days after birth and the remaining 20% of disease occurs between 8-90 days after birth. Studies carried out in the USA indicate that ...
Read Project

 10

 FINISHED 

Targeting alpha-particle emitting radionuclides to combat cancer (TARCC)

Start date: Jan 1, 2008, End date: Jun 30, 2011,

"This project aims at improving drug delivery to cancer cells by developing targeted radiotherapy with alpha-emitting radionuclides. Alpha particles emitted by radionuclides have short tracks (about 100 microns) in body tissues. As a result, they should be most appropriate to treat small-size tumours and isolated cancer cells. This project proposes the development of improved vectors and targeting ...
Read Project

 11

 FINISHED 

European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in children (CureHLH)

Start date: Jun 1, 2008, End date: May 31, 2011,

Haemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening inherited immune disorder of early childhood characterised by an uncontrolled immune response. Three disease causing genes have been identified in about half of the patients. Diagnosis is difficult, pathophysiology poorly understood, and treatment unsatisfactory with about 40% of the children dying from treatment failure or t ...
Read Project

 9

 FINISHED 

The Pathophysiology and Natural Course of Patients with Primary Antibody Deficiencies (PAD) (EURO-PADnet)

Start date: May 1, 2008, End date: Apr 30, 2011,

This medium-sized collaborative project will document and monitor the natural course and study the pathophysiology of Primary Antibody Deficiencies (PAD). PADs are rare inborn errors of the immune system with an estimated incidence of
Read Project

 13

 FINISHED 

"Pathophysiology of rare diseases due to ciliary dysfunction: nephronophthisis, Oral-facial-digital type 1 and Bardet-Biedl syndromes" (EUCILIA)

Start date: Feb 1, 2008, End date: Jan 31, 2011,

"Primary cilia have been recognized on nearly all-mammalian cells. Emerging data suggest that they act as cellular antennae with diverse motility and sensory functions, detecting a wide variety of signals. As such, defects in cilia formation or function have profound effects on the development of body pattern and the physiology of multiple organ systems. Ciliary defects underlie a wide range of hu ...
Read Project

 4

 FINISHED 

Identification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug development (TeloMarker)

Start date: Feb 1, 2008, End date: Jan 31, 2011,

Telomeres are DNA-nucleoprotein structures that protect the ends of human chromosomes through the formation of a ‘cap’ that prevents exonucleolytic degradation, inter- & intra-chromosomal fusion and subsequent chromosomal instability. Telomerase, the ribonucleoprotein enzyme that maintains linear chromosomal DNA ends by the addition of TTAGGG repeats, is completely repressed or present only at low ...
Read Project

 8